Summary
Acetylator status in 595 healthy Caucasian volunteers was determined with caffeine. The test group consisted of 372 males and 223 females, 18 to 78 years of age. 312 volunteers were smokers. Caffeine was taken orally as Coffein Comprette (200 mg caffeine × H2O) and urine was collected for 8 h. The metabolic ratio (MR) of 5-acetylamino-6-formylamino-1-methyluracil (AFMU) to 1-methyl-xanthine (MX) was determined by HPLC.
In total 61.7% of the group had a MR<0.48 and were classified as slow acetylators. MR varied from 0.01 to 0.47 in the slow acetylators and from 0.48 to 4.7 in the fast acetylator group. Clear dependence of acetylator type upon age, sex or smoking behaviour was not observed.
The present study has confirmed the caffeine test as a feasible tool to determine acetylation capacity.
This is a preview of subscription content, log in via an institution to check access.
References
Weber WW, Hein DW (1985) N-acetylation pharmacogenetics. Pharmacol Rev 37: 26–69
Weber WW (1973) Acetylation of drugs. In: Fishman WH (ed) Metabolic conjugation and metabolic hydrolysis, vol 3. Academic Press, New York, pp 249–296
Hughes HB, Biehl JP, Jones AP, Schmidt LH (1954) Metabolism in man as related to the occurrence of peripheral isoniazid neuritis. Am Rev Respir Dis 70: 266–273
Vree TB, O'Reilly WJ, Hekster YA, Damsma JE, van der Kleijn (1980) Determination of acetylator phenotype and pharmacokinetics of some sulphonamides in man. Clin Pharmacokinet 5: 274–294
Ludden TM, McNay JL, Shepherd AMM, Lin MS (1982) Clinical pharmacokinetics of hydralazine. Clin Pharmacokinet 7: 185–205
Reidenberg MM, Drayer DE, Levy M, Warner H (1975) Polymorphic acetylation of procainamide in man. Clin Pharmacol Ther 17: 722–730
Lima JJ, Jusko WJ (1978) Determination of procainamide acetylator status. Clin Pharmacol Ther 23: 25–29
Varughese P, Hamilton EJ, Eidus L (1974) Mass phenotyping of isoniazid inactivators by automated determination of acetylisoniazid in urine. Clin Chem 20: 639–641
Tang BK, Kadar D, Kalow W (1987) An alternative test for acetylator phenotyping with caffeine. Clin Pharmacol Ther 42: 509–513
Grant DM, Tang BK, Kalow W (1983) Variability of caffeine metabolism. Clin Pharmacol Ther 33: 591–602
Grant DM, Tang BK, Kalow W (1983) Polymorphic N-acetylation of caffeine metabolite. Clin Pharmacol Ther 33: 355–359
Grant DM, Tang BK, Kalow W (1984) A simple test for acetylator phenotype using caffeine. Br J Pharmacol 17: 459–64
Hildebrand M, Seifert W, Reichenberger A (1989) Determination of dextromethorphan metabolizer type in human volunteers. Eur J Clin Pharmacol 36: 315–318
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hildebrand, M., Seifert, W. Determination of acetylator phenotype in Caucasians with caffeine. Eur J Clin Pharmacol 37, 525–526 (1989). https://doi.org/10.1007/BF00558136
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558136